Biomarker-enhanced Artificial Intelligence Based Pediatric Sepsis Screening Tool
Biomarker-enhanced Artificial Intelligence Based Pediatric Sepsis Screening Tool Towards Early Recognition and Personalized Therapeutics
Sponsor: All Children's Research Institute
Listed as NCT05311046, this observational or N/A phase trial focuses on Sepsis and remains actively recruiting participants. Sponsored by All Children's Research Institute, it has been updated 7 times since 2026, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
7 versions recorded-
Oct 2025 — Present [monthly]
Not Yet Recruiting
Status: Active Not Recruiting → Not Yet Recruiting
-
Sep 2025 — Oct 2025 [monthly]
Active Not Recruiting
-
May 2025 — Sep 2025 [monthly]
Active Not Recruiting
Status: Recruiting → Active Not Recruiting
-
Sep 2024 — May 2025 [monthly]
Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Recruiting
▶ Show 2 earlier versions
-
Mar 2023 — Jul 2024 [monthly]
Recruiting
Status: Not Yet Recruiting → Recruiting
-
May 2022 — Mar 2023 [monthly]
Not Yet Recruiting
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- All Children's Research Institute
- Children's Hospital Medical Center, Cincinnati
- Computer Technology Associates, Inc.
- George Washington University
- Johns Hopkins University
- Rainbow Babies and Children's Hospital
For direct contact, visit the study record on ClinicalTrials.gov .